Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques

This publication has 43 references indexed in Scilit:

• Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting ofPlasmodium falciparumLiver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates
  Infection and Immunity, 2008
• Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein
  PLoS Medicine, 2007
• Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A
  Vaccine, 2006
• Alternating vector immunizations encoding pre‐erythrocytic malaria antigens enhance memory responses in a malaria endemic area
  European Journal of Immunology, 2006
• Merozoite Surface Protein 1 of Plasmodium vivax Induces a Protective Response against Plasmodium cynomolgi Challenge in Rhesus Monkeys
  Infection and Immunity, 2005
• The global distribution of clinical episodes of Plasmodium falciparum malaria
  Nature, 2005
• A high cell density fermentation strategy to produce recombinant malarial antigen in E. coli
  Biotechnology Letters, 2004
• A Novel Erythrocyte Binding Antigen-175 Paralogue fromPlasmodium falciparum Defines a New Trypsin-resistant Receptor on Human Erythrocytes
  Journal of Biological Chemistry, 2003
• Biochemical, Biophysical, and Functional Characterization of Bacterially Expressed and Refolded Receptor Binding Domain ofPlasmodium vivax Duffy-binding Protein
  Published by Elsevier ,2001
• Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
  Science, 1975